- 全部删除
 您的购物车当前为空 您的购物车当前为空
GJG057是一种高效和选择性的Leukotriene C4 synthase (LTC4S)抑制剂,在人全血LTC4释放试验中IC50=44 nM且具有口服活性,在小鼠哮喘加重模型中具有抗炎疗效,可用于治疗过敏性炎症。


为众多的药物研发团队赋能,
让新药发现更简单!
GJG057是一种高效和选择性的Leukotriene C4 synthase (LTC4S)抑制剂,在人全血LTC4释放试验中IC50=44 nM且具有口服活性,在小鼠哮喘加重模型中具有抗炎疗效,可用于治疗过敏性炎症。
| 规格 | 价格 | 库存 | 数量 | 
|---|---|---|---|
| 1 mg | ¥ 1,560 | In stock | |
| 5 mg | ¥ 3,780 | In stock | |
| 10 mg | ¥ 5,420 | In stock | |
| 25 mg | ¥ 8,130 | In stock | |
| 50 mg | ¥ 10,900 | In stock | |
| 100 mg | ¥ 14,800 | In stock | |
| 200 mg | ¥ 19,900 | In stock | 
GJG057 相关产品
| 产品描述 | GJG057 is a highly efficient and selective Leukotriene C4 synthase (LTC4S) inhibitor with an IC50 of 44 nM in human whole blood LTC4 release assays and oral activity. It demonstrates anti-inflammatory efficacy in a mouse asthma exacerbation model and can be used for the treatment of allergic inflammation. | 
| 靶点活性 |  LTC4S:44nM | 
| 别名 | GJG-057 | 
| 分子量 | 456.41 | 
| 分子式 | C21H21F5N4O2 | 
| CAS No. | 2761767-18-2 | 
| Smiles | O=C1N(C2=CC=C(F)C(F)=C2)C3(CCN(C=4N=CN=C(OCC(F)(F)F)C4)CC3)CCC1 | 
| 存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 40.00 mg/mL (87.64 mM), Sonication is recommended.  | ||||||||||||||||||||||||||||||
| 溶液配制表 | |||||||||||||||||||||||||||||||
| DMSO 
 | |||||||||||||||||||||||||||||||
 比如您的给药剂量是 10 mg/kg ,每只动物体重 20 g ,给药体积 100 μL ,
比如您的给药剂量是 10 mg/kg ,每只动物体重 20 g ,给药体积 100 μL ,  一共给药动物 10 只 ,您使用的配方为 5%
 一共给药动物 10 只 ,您使用的配方为 5%  DMSO+ 30%PEG300+ 5%Tween 80 + 60%Saline/PBS/ddH2O, 那么您的工作液浓度为 2 mg/mL 。
DMSO+ 30%PEG300+ 5%Tween 80 + 60%Saline/PBS/ddH2O, 那么您的工作液浓度为 2 mg/mL 。 
评论内容